ClinicalTrials.gg
CompletedNCT03490305ExlapUpdated Oct 16, 2018

Penetrating Abdominal Injuries From the Battle of Mosul

An observational study in Penetrating Abdominal Trauma and War Injury, sponsored by Vrinnevi Hospital. Completed at 1 site in Iraq. Per ClinicalTrials.gov, last updated 2018-10-16.

Sponsored by Vrinnevi Hospital · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
77
Sex
All
01

Study summary

The battle of Mosul was characterized by the use of improvised explosive devices, human shields and suicide bombers in an urban setting. It is unclear whether this type of warfare cause more extensive abdominal injuries to civilians than combatants. All patients admitted with penetrating abdominal injury subjected to an exploratory laparotomy at Emergency Hospital, Erbil, between October 17, 2016 and July 16, 2017 will be included. Differences in demographics, injury mechanism, time since injury, clinical status on arrival, intraoperative findings, postoperative complications and outcome will be studied.

Read the detailed description

Study Rationale The battle of Mosul was characterized by the use of improvised explosive devices, human shields and suicide bombers in an urban setting. It is unclear whether this type of warfare cause more extensive abdominal injuries to civilians than combatants. Understanding of the correlation between the severity of abdominal injuries, type of warfare and population affected is of importance when planning for surgical care in a conflict setting.

Aim To assess whether civilians obtain more extensive abdominal injuries than combatants in an urban battle characterized by the use of indiscriminate weapons.

Study Design An observational retrospective cohort study with longitudinal data collection.

All patients admitted with penetrating abdominal injury subjected to an exploratory laparotomy at Emergency Hospital, Erbil, between October 17, 2016 and July 16, 2017 will be included. Differences in demographics, injury mechanism, time since injury, clinical status on arrival, intraoperative findings, postoperative complications and outcome will be analysed.

Primary Objective Differences in injury mechanism, organs injured, surgical treatment given, postoperative complications and outcome between civilians and combatants.

Secondary Objectives Differences in surgical treatment given, postoperative complications and outcome between patients with prior surgical treatment of their injury and patients without prior surgical treatment.

Differences in surgical treatment given, postoperative complications and outcome between patients who receive surgical treatment less than 24 hours from injury and patients who receive surgical treatment more than 24 hours from injury will be analysed.

Statistical methods Differences between groups will be analysed using t-test and regression models.

02

Conditions studied

  • Penetrating Abdominal Trauma
  • War Injury

Keywords

  • War injury
  • Penetrating abdominal trauma
  • Exploratory laparotomy
  • Improvised explosive device
  • Mosul
03

In context

Lead sponsor

Vrinnevi Hospital is the lead sponsor of 6 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients admitted with penetrating abdominal injury subjected to an exploratory laparotomy at Emergency Hospital, Erbil, between October 17, 2016 and July 16, 2017 will be included.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Penetrating abdominal injury
  • Subjected to an exploratory laparotomy at Emergency Hospital, Erbil, Iraq
  • Between October 17, 2016 and July 16, 2017

Exclusion criteria

Exclusion Criteria (all must be fulfilled):

  • Patients who received treatment several times will only be counted as one patient
  • Between October 17, 2016 and July 16, 2017
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
77 participants (actual)
Target follow-up
4 Weeks
Patient registry
Yes

Groups and cohorts

  • Combatants

    Men 16-50 years old or combatants by own admission.

    Procedure: Exploratory laparotomy

  • Civilians

    Children \<16 years, all women and men ≥50 years.

    Procedure: Exploratory laparotomy

Interventions

  • ProcedureExploratory laparotomy

    Findings and procedures done at exploratory laparotomy

06

What researchers measure

Primary outcomes

  1. Differences in injury mechanism, organs injured, surgical treatment given, postoperative complications and outcome between civilians and combatants.

    Time frame: an average of 3 weeks

Secondary outcomes

  1. Differences in surgical treatment given, postoperative complications and outcome between patients with prior surgical treatment of their injury and patients without prior surgical treatment.

    Time frame: an average of 3 weeks

  2. Differences in surgical treatment given, postoperative complications and outcome between patients who receive surgical treatment less than 24 hours from injury and patients who receive surgical treatment more than 24 hours from injury will be analysed.

    Time frame: an average of 3 weeks

07

Study locations

1 site
  • Emergency Hospital
    Erbil, Kurdistan, Iraq
08

References and documents

Publications

  • Nassoura Z, Hajj H, Dajani O, Jabbour N, Ismail M, Tarazi T, Khoury G, Najjar F. Trauma management in a war zone: the Lebanese war experience. J Trauma. 1991 Dec;31(12):1596-9. doi: 10.1097/00005373-199112000-00005. PubMed 1749028 ↗
  • Coupland RM, Samnegaard HO. Effect of type and transfer of conventional weapons on civilian injuries: retrospective analysis of prospective data from Red Cross hospitals. BMJ. 1999 Aug 14;319(7207):410-2. doi: 10.1136/bmj.319.7207.410. PubMed 10445921 ↗
  • Sikic N, Korac Z, Krajacic I, Zunic J. War abdominal trauma: usefulness of Penetrating Abdominal Trauma Index, Injury Severity Score, and number of injured abdominal organs as predictive factors. Mil Med. 2001 Mar;166(3):226-30. PubMed 11263024 ↗
  • Cairns BA, Oller DW, Meyer AA, Napolitano LM, Rutledge R, Baker CC. Management and outcome of abdominal shotgun wounds. Trauma score and the role of exploratory laparotomy. Ann Surg. 1995 Mar;221(3):272-7. doi: 10.1097/00000658-199503000-00009. PubMed 7717780 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Nov 2017 to primary completion in Oct 2018, 10 months.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 22, 2018
First posted
Apr 6, 2018
StartActual
Nov 11, 2017
Primary completionActual
Oct 9, 2018
CompletionActual
Oct 10, 2018
Last update
Oct 16, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 16, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03490305
Lead sponsor
Vrinnevi Hospital
Collaborators
Emergency Hospital, Erbil, Iraq, Karolinska Institutet, Center for Disaster Medicine and Traumatology, Linköping University
Responsible party
Måns Muhrbeck (MD, Vrinnevi Hospital) — Principal investigator
First posted
Apr 6, 2018
Start date
Nov 11, 2017
Primary completion
Oct 9, 2018
Completion
Oct 10, 2018
Last update
Oct 16, 2018

Study contacts

Johan von Schreeb, MD, PhD
principal investigator · Karolinska Institutet

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion